BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

The Medicines Company 

8 Sylvan Way

Parsippany  New Jersey  07054  U.S.A.
Phone: 973-290-6000 Fax: 973-656-9898


SEARCH JOBS

View Clinical Trials from BioPharm Insight





Collaborations

UCB, Inc.  Contract manufacturing of Bivalirudin peptide active ingredient





 Company News
The Medicines Company (MDCO) To Announce First Quarter 2014 Financial Results On Wednesday, April 23, 2014 4/10/2014 10:24:30 AM    More...
FDA Accepts The Filing Of The Medicines Company (MDCO)'s US Biologic License Application For Fibrocaps Hemostatic Agent 4/4/2014 9:59:19 AM    More...
The Medicines Company (MDCO) Release: Update On Angiomax® (Bivalirudin) Patent Litigation 4/1/2014 11:01:28 AM    More...
Analysis Of EUROMAX And HORIZONS-AMI Trials Of The Medicines Company (MDCO)'s Angiomax(R) (Bivalirudin) Presented At American College of Cardiology14 3/31/2014 8:53:35 AM    More...
The Medicines Company (MDCO) To Participate In 2014 Barclays Global Healthcare Conference 3/7/2014 9:40:28 AM    More...
European Medicines Agency Accepts Marketing Authorization Application For The Medicines Company (MDCO)'s Oritavancin 2/27/2014 9:52:42 AM    More...
The Medicines Company (MDCO) Reports Fourth Quarter And Full Year 2013 Financial Results 2/20/2014 10:01:38 AM    More...
The Medicines Company (MDCO) To Participate In Upcoming Healthcare Investor Conferences 2/20/2014 9:29:30 AM    More...
FDA Accepts Filing Of The Medicines Company (MDCO)'s New Drug Application For Intravenous Antibiotic Oritavancin With Priority Review 2/19/2014 10:50:48 AM    More...
The Medicines Company (MDCO) Stock Trading Halted Today 2/12/2014 9:44:55 AM    More...
12345678910...